Sensorion announces its participation in the conference
Van Lanschot Kempen’s Life Sciences
Montpellier, April 10, 2024, at 7:30 a.m. CET – Sensorion (FR0012596468 – ALSEN), a pioneering clinical-stage biotechnology company specializing in the development of new therapies to restore, treat and prevent hearing loss disorders, today announces its participation in the Van Lanschot Kempen’s Life Sciences conference to be held on April 16 and 17, 2024, in Amsterdam, the Netherlands.
Sensorion’s management team will attend the conference in person on April 16, 2024 and will be available for meetings with investors throughout the day.